Archive - Latest News Search Engine - Global and Local Breaking News

Seahawks have the most experienced 2025 NFL draft rookie class in the league

Seahawks have the most experienced 2025 NFL draft rookie class in the league

Lumeris and MIT Computational Biology Lab Partner to Solve America's 2 Billion Hour Primary Care Gap

Lumeris and MIT Computational Biology Lab Partner to Solve America's 2 Billion Hour Primary Care Gap

Biohaven Enrolls First Patient into Phase 2/3 Trial in Early Parkinson's Disease, Targeting Neuroinflammation with Novel Brain-Penetrant TYK2/JAK1 Inhibitor

Biohaven Enrolls First Patient into Phase 2/3 Trial in Early Parkinson's Disease, Targeting Neuroinflammation with Novel Brain-Penetrant TYK2/JAK1 Inhibitor

I'm in my 40s. Is it too late to try Botox?

I'm in my 40s. Is it too late to try Botox?

Your briefing

Seahawks have the most experienced 2025 NFL draft rookie class in the league

The Seattle Seahawks have the most experienced 2025 NFL draft rookie class in the league.

Seahawks have the most experienced 2025 NFL draft rookie class in the league

Lumeris and MIT Computational Biology Lab Partner to Solve America's 2 Billion Hour Primary Care Gap

Collaboration advances AI-driven Primary Care as a Service™ through next-gen computational models ST. LOUIS, May 29, 2025 /PRNewswire/ -- Lumeris, a l...

Lumeris and MIT Computational Biology Lab Partner to Solve America's 2 Billion Hour Primary Care Gap

Biohaven Enrolls First Patient into Phase 2/3 Trial in Early Parkinson's Disease, Targeting Neuroinflammation with Novel Brain-Penetrant TYK2/JAK1 Inh...

BHV-8000 is a first-in-clinic, brain-penetrant, and selective inhibitor of TYK2 and JAK1 kinases — a novel investigational therapy with the potential ...

Biohaven Enrolls First Patient into Phase 2/3 Trial in Early Parkinson's Disease, Targeting Neuroinflammation with Novel Brain-Penetrant TYK2/JAK1 Inhibitor

I'm in my 40s. Is it too late to try Botox?

I'm in my 40s. Is it too late to try Botox?